by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Abstract INTRODUCTION Alzheimer’s disease (AD) is now diagnosed biologically. Since subjective cognitive decline (SCD) may indicate preclinical AD, assessing AD-biomarkers is crucial. We investigated cognitive and neurodegenerative trajectories in SCD over 24...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Abstract INTRODUCTION Type 2 diabetes increases the risk of Alzheimer’s disease (AD) dementia. Insulin signaling dysfunction exacerbates tau protein phosphorylation, a hallmark of AD pathology. However, the comprehensive impact of diabetes on patterns of...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Anthony E. Lang, Günter U. Höglinger, Charles H. Adler, Daniela...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Alzheimer’s &Dementia, EarlyView. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Clifford R. Jack Jr. | December 29, 2024 Wiley:...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Abstract INTRODUCTION Women with early bilateral salpingo-oophorectomy (BSO) have greater Alzheimer’s disease (AD) risk than women with spontaneous menopause (SM), but the pathway toward this risk is understudied. Considering associative memory deficits may...
by Clinical Neuropsychologist | Sunday, December 29, 2024 | Dementia
Abstract INTRODUCTION Neuropsychiatric symptoms (NPSs) are common in dementia with Lewy bodies (DLB) but their neurobiological mechanisms are poorly understood. METHODS NPSs and cognition were assessed annually in participants (DLB n = 222; Alzheimer’s disease...
